Web Desc
Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus
joint with Brain Therapeutics: Disruptive Technologies and Opportunities
Organizer(s): Edwin S. Monuki, Maria Lehtinen and Maiken Nedergaard
Date: February 16 - 19, 2020
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Supported by the Directors' Fund
For important information on the coronavirus, please click here
Summary of Meeting:
The cerebrospinal fluid (CSF) has long been a 'missing link' in our understanding of brain form, function, and disease. However, recent work has begun to illuminate how the CSF regulates the brain in ways that extend far beyond its passive historical roles and provides unique opportunities for studying, diagnosing, and potentially treating brain disorders. This Keystone Symposia conference brings together an interdisciplinary group of new and established scientists to discuss this newfound excitement about CSF. Talks will feature discoveries about CSF sources (choroid plexus), routes (glymphatics), drainage (lymphatics) and clinical utilities. This conference aims to coalesce an international community that can propel CSF research forward by fostering new ideas, collaborations, and training opportunities. Held jointly with Keystone Symposia’s ‘Brain Therapeutics: Disruptive Technologies and Opportunities for Drug Development,’ the goal of this paring is to stimulate thinking about CSF-based medicinal therapies. CSF has therapeutic advantages over blood because it is 'behind' the blood-brain barrier and equilibrating with the interstitial fluid surrounding brain cells.
Scholarship Deadline: October 29 2019
Discounted Abstract Deadline: October 29 2019
Abstract Deadline: November 19 2019
Discounted Registration Deadline: December 17 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.


We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS115398-01
Funding for this conference was made possible (in part) by 1R13NS115398-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found